Clinical Trials Logo

Angina, Stable clinical trials

View clinical trials related to Angina, Stable.

Filter by:

NCT ID: NCT03963609 Completed - Clinical trials for Chronic Stable Angina

Multi-slice CT Coronary Angiography in Patients With Stable Angina

Start date: January 1, 2016
Phase:
Study type: Observational

early identification of vulnerable plaques by remodeling index prior to rupture and development of acute event is of considerable importance especially by a reliable non-invasive method as CT coronary angiography.

NCT ID: NCT03935542 Completed - Unstable Angina Clinical Trials

Assessment of Diagonal Branch Territory

Start date: August 3, 2015
Phase:
Study type: Observational

This study was performed to investigate the anatomical attributes that determine myocardial territory of diagonal branches and to develop a prediction model for clinically relevant branches using myocardial perfusion imaging (MPI) and coronary CT angiography (CCTA).

NCT ID: NCT03923153 Completed - Angina, Stable Clinical Trials

Effectiveness of Inspiratory Muscle Training in Patient With Stable Angina

Start date: April 15, 2019
Phase: N/A
Study type: Interventional

Stable angina is a cardiac pathology that adversely affects the quality of life of the patient, which develops as a result of narrowing of the coronary vessels developing in atherosclerotic ground and / or impaired oxygen supply-need balance. Studies widely investigated the effects of exercise training in patients with stable angina. No study investigated the effects of inspiratory muscle training in patients with stable angina.Investigators aimed to investigate the effects of inspiratory muscle training on aerobic exercise capacity, quality of life, depression, peripheral and respiratory (MIP, MEP) muscle strength, pulmonary function, dyspnea, fatigue in stable angina patients.

NCT ID: NCT03866395 Completed - Clinical trials for Angina Pectoris, Stable

Effects of Ivabradine on Residual Myocardial Ischemia After PCI

Start date: March 5, 2015
Phase: Phase 4
Study type: Interventional

This is a randomized pharmacological study evaluating the effects of ivabradine in patients with residual angina after PCI. The role of ivabradine in patients with angina, without systolic dysfunction, is not yet clear. The investigators performed in all patients an echostress to evaluate the effects of therapy with ivabradine after 30 days in terms of exercise tolerance and diastolic function.

NCT ID: NCT03815032 Completed - Clinical trials for Coronary Artery Disease

Assessing the Accuracy of the OptoWire DeuxTM in a Wire to Wire Comparison

ACCURACY
Start date: February 1, 2019
Phase: N/A
Study type: Interventional

The goal of the ACCURACY study is to assess the differences, if any, in FFR measurements made by the OptoWire Deux FFR guidewire by comparison of simultaneous data of two different OptoWire DeuxTM guidewires (group 1). In addition, the investigators will compare (group 2) the FFR measurements obtained from an OptoWire Deux FFR guidewire and compare it to the FFR measurement by a VERRATA-TM guidewire to assess coronary stenosis in the routine clinical practice.

NCT ID: NCT03759067 Completed - Angina, Stable Clinical Trials

Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina Patients

MECCA
Start date: October 18, 2010
Phase: N/A
Study type: Interventional

The study included 511 patients who underwent PCI because of angina during 2010-2011 at three Korean hospitals. Clopidogrel-naïve patients received either a loading dose (LD; 600 mg at 2-24 h before the procedure) or routine maintenance therapy (75 mg/day for ≥5 days) plus either a 300-mg reload (RL) or only the maintenance dose (MD).

NCT ID: NCT03742050 Completed - Stable Angina Clinical Trials

A Placebo-controlled Trial of Percutaneous Coronary Intervention for the Relief of Stable Angina

ORBITA-2
Start date: November 12, 2018
Phase: N/A
Study type: Interventional

ORBITA-2 is a double blinded randomised placebo-controlled trial comparing the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy. Follow-up will be at 12 weeks.

NCT ID: NCT03718559 Completed - Clinical trials for Coronary Artery Disease

Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease

EPIC-CAD
Start date: May 14, 2019
Phase: Phase 4
Study type: Interventional

This study evaluates the efficacy and safety of Edoxaban with the combination of edoxaban and antiplatelet in patients with stable CAD (coronary artery stenosis ≥50% on medical treatment or revascularized stable CAD [≥ 12 months for acute coronary syndrome and ≥ 6 months after stable CAD]) and high-risk atrial fibrillation (CHA2DS2-VASc score ≥2).

NCT ID: NCT03690713 Completed - Stable Angina Clinical Trials

International Collaboration of Comprehensive Physiologic Assessment

Start date: June 1, 2018
Phase:
Study type: Observational

The current study evaluated prognostic implication of comprehensive physiologic assessment using fractional flow reserve, coronary flow reserve (CFR) and index of microcirculatory resistance (IMR).

NCT ID: NCT03539627 Completed - Diabetes Mellitus Clinical Trials

Azilsartan Medoxomil in Hypertensive pAtients With Stable Ischemic Heart Disease and DiabEtes MEllitus.

AcADEME
Start date: November 7, 2018
Phase:
Study type: Observational

One-center, observational, non-interventional, prospective study of the efficacy of azilsartan medoxomil in patients with arterial hypertension associated with stable ischemic heart disease and type 2 diabetes mellitus.